Wyeth Premarin Petition Withdrawn; Firm Hints At Future Action

Wyeth is reserving its right to file future citizen petitions with regard to the manufacturing of generic Premarin (conjugated estrogens), the company says in a letter formally withdrawing a 1994 petition to block synthetically derived estrogens